Product
Sodium zirconium cyclosilicate
Aliases
Lokelma
4 clinical trials
7 indications
Indication
HyperkalemiaIndication
Oral Potassium BindersIndication
Congestive Heart FailureIndication
Diet ModificationIndication
chronic kidney diseaseIndication
LokelmaClinical trial
Phase IV, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Trial Evaluating Sodium Zirconium Cyclosilicate (SZC) for the Management of Hyperkalaemia in Patients With Symptomatic Heart Failure With Reduced Ejection Fraction and Receiving SpironolactoneStatus: Active (not recruiting), Estimated PCD: 2024-07-31
Clinical trial
Comparison of Potassium Binders in the ERStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure - Efficacy and Safety of Sodium Zirconium Cyclosilicate in Optimizing Mineralocorticoid Receptor Antagonists Therapy in Heart FailureStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4Status: Not yet recruiting, Estimated PCD: 2025-05-01